Tioguanin clinical trials
Tioguanin is named as an intervention in 8 current clinical trials in our Australia, Canada, Israel, Mexico, Germany, Italy, Switzerland, Austria, Czechia, France, Netherlands, Belgium and Sweden registers. 3 are recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is National Cancer Institute (NCI) (4). The most-studied condition is B Acute Lymphoblastic Leukemia.
What health systems spend on Tioguanin
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
Patient leaflets for Tioguanin
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- IEIreland: 1 product on the HPRA listEach product record links to the HPRA, which publishes the leaflet and SmPC.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Tioguanin
8 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Tioguanin across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Licensed in Ireland (HPRA)
1 single-substance product containing Tioguanin on the HPRA medicines list.
- Lanvis 40mg TabletsAspen Pharma Trading Limited · PA1691/006/001 · Not marketed
Supply shortages
No entry for Tioguanin in the EMA, FDA or German BfArM shortage lists we track.
Conditions studied with Tioguanin
16 conditionsAll 16 conditions
| Condition (as registered) | Trials |
|---|---|
| B Acute Lymphoblastic Leukemia | 4 |
| Mixed Phenotype Acute Leukemia | 2 |
| Down Syndrome | 2 |
| B Lymphoblastic Lymphoma | 2 |
| Acute Lymphoblastic Leukemia, Pediatric | 1 |
| Acute Lymphoblastic Leukemia | 1 |
| T Acute Lymphoblastic Leukemia | 1 |
| Acute Myeloid Leukemia | 1 |
| Myelodysplastic Syndrome | 1 |
| Myeloid Leukemia Associated With Down Syndrome | 1 |
| Recurrent B Acute Lymphoblastic Leukemia | 1 |
| Adult T Acute Lymphoblastic Leukemia | 1 |
| Ann Arbor Stage II Adult Lymphoblastic Lymphoma | 1 |
| Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | 1 |
| Ann Arbor Stage III Adult Lymphoblastic Lymphoma | 1 |
| Central Nervous System Leukemia | 1 |
Sponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Children's Oncology Group | 3 |
| Martin Schrappe | 1 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Tioguanin trials
How many clinical trials are testing Tioguanin?
8 current trials in our Australia, Canada, Israel, Mexico, Germany, Italy, Switzerland, Austria, Czechia, France, Netherlands, Belgium and Sweden registers name Tioguanin as a drug or biological intervention, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.
Are Tioguanin trials recruiting patients?
Yes. 3 of the 8 trials are recruiting: 3 with sites in Australia, 2 with sites in Canada, 2 with sites in Israel, 2 with sites in Mexico, 1 with sites in Germany, 1 with sites in Italy, 1 with sites in Switzerland, 1 with sites in Austria and 1 with sites in Czechia. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Tioguanin clinical trials?
National Cancer Institute (NCI) (4), Children's Oncology Group (3) and Martin Schrappe (1). The number in brackets is how many trials each organisation leads.
Is Tioguanin licensed in Ireland?
Yes. The HPRA medicines list includes 1 single-substance product containing Tioguanin, for example Lanvis 40mg Tablets (Aspen Pharma Trading Limited). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
Is there a Tioguanin shortage?
Not in the lists we track: Tioguanin has no entry in the EMA, FDA or German BfArM shortage registers as of their latest sync.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Tioguanin works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Tioguanin works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Tioguanin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.